• 1349 Citations
19982020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrew Porter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Sharks Medicine & Life Sciences
Antigen Receptors Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Uveitis Medicine & Life Sciences
Biological Products Medicine & Life Sciences
Nanoconjugates Chemical Compounds
Saprolegnia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2020

  • 1349 Citations
  • 43 Article
  • 1 Patent
Open Access
File
Enzyme-Linked Immunosorbent Assay
Pharmaceutical Preparations
Anti-Idiotypic Antibodies
Serum
Therapeutics
2 Citations (Scopus)
5 Downloads (Pure)
Open Access
File
Antigen Receptors
Transgenic Mice
Autoimmune Diseases
Arthritis
Tumor Necrosis Factor-alpha
4 Downloads (Pure)

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Abdelwahab, E. M. M., Pal, S., Kvell, K., Sarosi, V., Bai, P., Rue, R., Krymskaya, V., McPhail, D., Porter, A. & Pongracz, J. E., 2019, In : Oncogene. 38, p. 3093-3101 9 p.

Research output: Contribution to journalArticle

Open Access
File
Lymphangioleiomyomatosis
Rare Diseases
Lung
Lung Transplantation
Organelle Biogenesis
2 Citations (Scopus)

Oriented attachment of VNAR proteins, Q2 via site-selective modification, on PLGA–PEG nanoparticles enhances nanoconjugate performance

Nogueira, J. C. F., Greene, M. K., Richards, D. A., Furby, A. O., Steven, J., Porter, A., Barelle, C., Scott, C. J. & Chudasama, V., 7 Jul 2019, In : Chemical Communications. 55, 53, p. 7671-7674 4 p.

Research output: Contribution to journalArticle

Open Access
File
Nanoconjugates
Antigen Receptors
Glycols
Antigens
Nanoparticles
1 Downloads (Pure)

Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand

Pepple, K. L., Wilson, L., Van Gelder, R. N., Kovaleva, M., Ubah, O. C., Steven, J., Barelle, C. J. & Porter, A., Sep 2019, In : Translational vision science & technology. 8, 5, 13 p., 11.

Research output: Contribution to journalArticle

Open Access
File
Sharks
Antigen Receptors
T-cells
Uveitis
Antigens